Caisse Des Depots Et Consignations’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.38M Sell
42,257
-9,509
-18% -$784K 0.06% 92
2025
Q4
$4.41M Sell
51,766
-12,427
-19% -$1.02M 0.1% 85
2025
Q3
$4.99M Sell
64,193
-4,197
-6% -$328K 0.21% 73
2025
Q2
$5.35M Sell
68,390
-3,831
-5% -$286K 0.22% 76
2025
Q1
$5.23M Sell
72,221
-4,021
-5% -$288K 0.25% 72
2024
Q4
$5.64M Buy
+76,242
New +$5.34M 0.28% 57

Other funds holding EW

Caisse Des Depots Et Consignations's EW Position: Q1 2026 in Review

Caisse Des Depots Et Consignations reduced its Edwards Lifesciences (EW) stake by 18% in Q1 2026, selling an estimated $784K and leaving 42,257 shares worth $3.38M. The position accounts for 0.06% of the portfolio, ranked #92.

Caisse Des Depots Et Consignations first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.64M in Q4 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Caisse Des Depots Et Consignations held 42,257 shares of Edwards Lifesciences worth $3.38M as of Q1 2026.
  • Caisse Des Depots Et Consignations sold 9,509 Edwards Lifesciences shares in Q1 2026, an estimated $784K.
  • Edwards Lifesciences made up 0.06% of Caisse Des Depots Et Consignations's portfolio in Q1 2026, its #92 holding.
  • Caisse Des Depots Et Consignations first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • Caisse Des Depots Et Consignations's Edwards Lifesciences position peaked at $5.64M in Q4 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Caisse Des Depots Et Consignations's 13F filing for Q1 2026, filed 30 Apr 2026.